54 related articles for article (PubMed ID: 11673832)
21. Biomolecular markers in cancer of the tongue.
Ferrari D; Codecà C; Fiore J; Moneghini L; Bosari S; Foa P
J Oncol; 2009; 2009():412908. PubMed ID: 19696947
[TBL] [Abstract][Full Text] [Related]
22. EGFR protein overexpression and gene copy number increases in oral tongue squamous cell carcinoma.
Ryott M; Wangsa D; Heselmeyer-Haddad K; Lindholm J; Elmberger G; Auer G; Avall Lundqvist E; Ried T; Munck-Wikland E
Eur J Cancer; 2009 Jun; 45(9):1700-8. PubMed ID: 19332367
[TBL] [Abstract][Full Text] [Related]
23. Targeting EGFR resistance networks in head and neck cancer.
Ratushny V; Astsaturov I; Burtness BA; Golemis EA; Silverman JS
Cell Signal; 2009 Aug; 21(8):1255-68. PubMed ID: 19258037
[TBL] [Abstract][Full Text] [Related]
24. ErbB receptors in the biology and pathology of the aerodigestive tract.
Morgan S; Grandis JR
Exp Cell Res; 2009 Feb; 315(4):572-82. PubMed ID: 18778701
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of fatty acid synthase (FAS) and ErbB2 in nonmalignant and malignant oral keratinocytes.
Silva SD; Cunha IW; Rangel AL; Jorge J; Zecchin KG; Agostini M; Kowalski LP; Coletta RD; Graner E
Virchows Arch; 2008 Jul; 453(1):57-67. PubMed ID: 18528705
[TBL] [Abstract][Full Text] [Related]
26. The ERBB3 receptor in cancer and cancer gene therapy.
Sithanandam G; Anderson LM
Cancer Gene Ther; 2008 Jul; 15(7):413-48. PubMed ID: 18404164
[TBL] [Abstract][Full Text] [Related]
27. Chemoprevention of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamster cheek pouch by topical application of a dual inhibitor of epidermal growth factor receptor (EGFR) and ErbB2 tyrosine kinases.
Sun Z; Sood S; Li N; Yang P; Newman RA; Yang CS; Chen X
Oral Oncol; 2008 Jul; 44(7):652-7. PubMed ID: 17936675
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of erbB2 and erbB3 expression during oral oncogenesis in diabetic rats.
Vairaktaris E; Goutzanis L; Vassiliou S; Spyridonidou S; Nkenke E; Papageorgiou G; Strantzias P; Lazaris A; Yapijakis C; Patsouris E
J Cancer Res Clin Oncol; 2008 Mar; 134(3):337-44. PubMed ID: 17704947
[TBL] [Abstract][Full Text] [Related]
29. Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth.
Määttä JA; Sundvall M; Junttila TT; Peri L; Laine VJ; Isola J; Egeblad M; Elenius K
Mol Biol Cell; 2006 Jan; 17(1):67-79. PubMed ID: 16251361
[TBL] [Abstract][Full Text] [Related]
30. Prognostic significance of EGFR and Her-2 in oral cavity cancer in betel quid prevalent area cancer prognosis.
Chen IH; Chang JT; Liao CT; Wang HM; Hsieh LL; Cheng AJ
Br J Cancer; 2003 Aug; 89(4):681-6. PubMed ID: 12915878
[TBL] [Abstract][Full Text] [Related]
31. The role of epidermal growth factor receptor in head and neck squamous cell carcinoma.
Pomerantz RG; Grandis JR
Curr Oncol Rep; 2003 Mar; 5(2):140-6. PubMed ID: 12583831
[TBL] [Abstract][Full Text] [Related]
32. Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients.
Bei R; Budillon A; Masuelli L; Cereda V; Vitolo D; Di Gennaro E; Ripavecchia V; Palumbo C; Ionna F; Losito S; Modesti A; Kraus MH; Muraro R
J Pathol; 2004 Nov; 204(3):317-25. PubMed ID: 15476268
[TBL] [Abstract][Full Text] [Related]
33. ErbB receptor tyrosine kinase inhibitors as therapeutic agents.
Anderson NG; Ahmad T
Front Biosci; 2002 Sep; 7():d1926-40. PubMed ID: 12161338
[TBL] [Abstract][Full Text] [Related]
34. Small molecule inhibitors targeting the EGFR/ErbB family of protein-tyrosine kinases in human cancers.
Roskoski R
Pharmacol Res; 2019 Jan; 139():395-411. PubMed ID: 30500458
[TBL] [Abstract][Full Text] [Related]
35. Co-localization of multiple ErbB receptors in stratified epithelium of oral squamous cell carcinoma.
Bei R; Pompa G; Vitolo D; Moriconi E; Ciocci L; Quaranta M; Frati L; Kraus MH; Muraro R
J Pathol; 2001 Oct; 195(3):343-8. PubMed ID: 11673832
[TBL] [Abstract][Full Text] [Related]
36. ERBB receptors in developing, dysplastic and malignant oral epithelia.
Rautava J; Jee KJ; Miettinen PJ; Nagy B; Myllykangas S; Odell EW; Soukka T; Morgan PR; Heikinheimo K
Oral Oncol; 2008 Mar; 44(3):227-35. PubMed ID: 17604679
[TBL] [Abstract][Full Text] [Related]
37. ErbB receptors and fatty acid synthase expression in aggressive head and neck squamous cell carcinomas.
Silva SD; Cunha IW; Younes RN; Soares FA; Kowalski LP; Graner E
Oral Dis; 2010 Nov; 16(8):774-80. PubMed ID: 20604875
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
